The earlier studies suggested that DKK4 was down-regulated in human tumors, for example in hepatocellular carcinoma and colorectal cancer, which indicated that DKK4 might act as a tumor suppressor by inhibiting Wnt/β-catenin signaling [11–14]. Here, DKK4 is linked to neoplasm.